Genetics of hemostasis: Differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families

Environmental Health Perspectives

Volumn 116, Issue 6, 2008, Pages 839-843

  Nowak Göttl, Utrike ^a   Langer, Claus ^a   Bergs, Sandra ^a   Thedieck, Sabine ^a   Sträter, Ronald ^a   Stoll, Monika ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Heritability; Household; Lifestyle; Pediatric strole; Smoking

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 3A; BLOOD CLOTTING FACTOR 5; CHOLESTEROL; D DIMER; FATTY ACID BINDING PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLASMA PROTEIN; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN FRAGMENT F1.2; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD GROUP; BLOOD SAMPLING; CHILD; CHILD HEALTH CARE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEMOSTASIS; HERITABILITY; HORMONAL CONTRACEPTION; HOUSEHOLD; HUMAN; LIFESTYLE MODIFICATION; LINKAGE ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PEDIGREE ANALYSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SMOKING; STROKE; VARIANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; FACTOR V; FAMILY HEALTH; FEMALE; HEMOSTASIS; HUMANS; INFANT; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PEDIGREE; PROTEIN C; PROTEIN S; PROTHROMBIN; SMOKING; STROKE;

EID: 46749108885     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10754     Document Type: Article

References (45)

1. Almasy L, Blangero J. 1998. Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211.
2. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et at. 1994. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 83:1251-1257.
3. Ariens RAS, de Lange M, Snieder H, Boothby M, Spector TD, Grand PJ. 2002. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet 359:667-671.
4. Beekman M, Heijmans BT, Martin NG, Pedersen NL, Whitfield JB, DeFaire U, et al. 2002. Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res 5:87-97.
5. Broackel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, et al. 2002. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 30:210-204.
6. Comuzzie AG, Williams JT. 1999. Correcting for ascertainment bias in the COGA data set. 1999. Genet Epidemiol 17(suppl 1):S109-S114.
7. Czerwinski SA, Mahaney MC, Rainwater DL, Vandeberg JL, MacCluer JW, Stern MP, et al. 2004. Gene by smoking interacton: evidence for effects on law-density lipoprotein size and plasma levels of triglyceride and high-density lipoprotein cholesterol. Hum Biol 76:883-876.
8. de Lange M, Snieder H, Ariens RAS, Spector TD, Grant PJ. 2001. The genetics of haemostasis: a twin study. Lancet 357:101-105.
9. Düring C, Kosch A, Langer C, Thedieck S, Nowak-Göttl U. 2004. Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thrombosis and stroke. Thromb Hasmost 92:707-712.
10. Edwards KL, Mahoney MC, Motulsky AG, Austin MA. 1999, Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families. Arterioscler Thromb Vasc Biol 19:2456-2464.
11. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. 2002. Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arterioscler Thromb Vasc Biol 22:506-510.
12. Gardner GD, Fortmann SP, Krauss RM. 1996. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875-881.
13. Haywood S, Liesner R, Pindora S, Ganesen V. 2005. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child 90:402-405.
14. Heller C, Heinecke A, Junker R, Knofler R, Kasch A, Kurnik K, et al. 2003. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 108:1362-1367.
15. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. 1993. Genetic and environmental influence on serum lipid levels in twins. N Engl J Med 338:1150-1156.
16. Israels SJ. Seshia SS. 1987. Childhood stroke associated with protein C or S deficiency. J Pediatr 111:562-564.
17. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. 1999. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 19:2568-2572.
18. Kirkham FJ, Prengler M, Hewes KM, Ganesan V. 2000. Risk factors for arterial ischemic stroke in children. J Child Neurol 15: 299-307.
19. Kobelt K, Biasiutti FD, Mattle HP, Lämmle B, Wuillemin A. 2001. Protein Z in ischaemic stroke. Br J Haematol 114: 169-173.
20. Kreuz W, Stoll M, Junker R, Heinecke A, Heinecke A, Schobess R, et al. 2006. Familial elevated factor VIII in children with symptomatic venous thrombosis and postthrombotic syndrome. Results of a multicentre study. Arterioscler Thromb Vasc Biol 26:1901-1906.
21. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, et al. 1998. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279:1955-1961.
22. Lichy C, Kropp S, Dong-Si T, Genius J, Dolan T, Hampe T, et al. 2004. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 35:40-45.
23. McQuillan AM, Eikelboom JW, Hankey GJ, Baker R, Thom J, Staten J, et al. 2003. Protein Z in ischemic Stroke and its etiologic subtypes. Stroke 34:2415-2419.
24. Middelberg RP, Martin NG, Whitfield JB. 2006. Longitudinal genetic analysis of plasma lipids. Twin Res Hum Genet 9:550-557.
25. Middelberg RPS, Spector TD, R Swaminathan, H. Snieder. 2002. Genetic and environmental influences on lipids, lipoproteins and apolipoproteins. Effects of menopause. Arterioscler Thromb Vasc Biol 22:1142-1147.
26. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, et al. 1996. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94:2159-2170.
27. Mosher MJ, Martin LJ, Cupples LA, Yang Q, Dyer TD, Williams JT, et al. 2005. Genotype-by-sex interaction in the regulation of high-density lipoprotein: the Framingham Heart Study. Hum Biol 77:773-793.
28. Nicolaides P, Appelton RE. 1996. Stroke in children. Dev Med Clin Neurol 38:173-180.
29. Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Münchow N, Assmann G, et al. 1999a. Increased lipoprotein (a) is an important risk factor for venous thrombosis in childhood. Circulation 100:743-748.
30. Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, et al. 1999b. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetatrahydrofolate reductase are risk factors of spontaneous ischaemic stroke in childhood. Blood 94:3678-3682.
31. Perusse L, Rice T, Despres JP, Bergeron J, Province MA, Gagnon J, et al. 1997. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE family study. Arterioscler Thromb Vasc Biol 17:3263-3269.
32. Ravi S, Mauron T, Lämmle B, Wuillemin WA. 1998. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br J Haematol 102:1219-1223.
33. Saunders CL, Gulifford MC. 2006. Heritabilities and shared environmental effects were estimated from household clustering in national health survey data. J Clin Epidemiol 59:11911-1198.
34. Schmídt B, Andrew M. 1995. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96:939-943.
35. Schoenberg B, Mellinger J, Schoenberg O. 1978. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology 28:763-768.
36. Scholz M, Kraft HG, Lingenhel A, Delport R, Delport R, Vorster EH, et al. 1999. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum Genet 7:169-178.
37. Snieder H, van Doornen LJP, Boomsma DI. 1997. The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Genet 60:638-650.
38. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, et al. 2000. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101:1546-1551.
39. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, et al. 1996. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276:882-888.
40. Staton J, Sayer M, Hankey GJ, Cole V, Thom J, Eikelboom JW. 2005. Protein Z gene polymorphisms, protein Z concentrations, and ischaemic stroke. Stroke 36:1123-1127.
41. Stephens JW, Humphries SE. 2003. The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 253:120-127.
42. Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, et al. 2002. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 350:1540-1545.
43. Vasse M, Guegan-Massardier E, Borg JY, Woimant F, Soria C. 2001. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 351:993-994.
44. Vossen CY, Hasstedt SJ, Rosendaal FR, Callas PW, Bauer KA, Broze GJ, et al. 2004. Heritability of plasma concentrations of clotting factors and measurements of a prethrombotic state in a protein C-deficient family. J Thromb Haemost 2:242-247.
45. World Medical Association. 2002. Declaration of Helsinki. Available: http://www.wma.net/a/policy/b3.htm [accessed 9 October 2004].